Paul Lévesque
Chief Executive Officer bij THERATECHNOLOGIES INC.
Vermogen: 120 848 $ op 31-03-2024
Profiel
Paul Lévesque is currently the President, Chief Executive Officer & Director at Theratechnologies, Inc. He previously worked as the Global President-Rare Disease at Pfizer Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed his undergraduate degree at McGill University and Université Laval.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0.16% | 21-01-2024 | 72 800 ( 0.16% ) | 120 848 $ | 31-03-2024 |
Actieve functies van Paul Lévesque
| Bedrijven | Functie | Begin |
|---|---|---|
| THERATECHNOLOGIES INC. | Chief Executive Officer | 06-04-2020 |
Eerdere bekende functies van Paul Lévesque
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 06-04-2020 |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Paul Lévesque
| Université Laval | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
